These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25440559)

  • 21. [The efficacy of needle exchange programs in the prevention of HIV and hepatitis infection among injecting drug users].
    Takács IG; Demetrovics Z
    Psychiatr Hung; 2009; 24(4):264-81. PubMed ID: 19949245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lethal injections: the law, science, and politics of syringe access for injection drug users.
    Burris S; Strathdee SA; Vernick JS
    Univ San Francisco Law Rev; 2003; 37(4):813-85. PubMed ID: 15457636
    [No Abstract]   [Full Text] [Related]  

  • 23. Background demographics and risk behaviors of injecting drug users in Karachi, Pakistan.
    Parviz S; Fatmi Z; Altaf A; McCormick JB; Fischer-Hoch S; Rahbar M; Luby S
    Int J Infect Dis; 2006 Sep; 10(5):364-71. PubMed ID: 16793307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
    Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
    Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug policy in Vietnam: a decade of change?
    Vuong T; Ali R; Baldwin S; Mills S
    Int J Drug Policy; 2012 Jul; 23(4):319-26. PubMed ID: 22206713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of the number of injecting drug users attending an outreach syringe-exchange program and infection with human immunodeficiency virus (HIV) and hepatitis C virus: the AjUDE-Brasil project.
    Caiaffa WT; Mingoti SA; Proietti FA; Carneiro-Proietti AB; Silva RC; Lopes AC; Doneda D
    J Urban Health; 2003 Mar; 80(1):106-14. PubMed ID: 12612100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention.
    Koester S; Glanz J; Barón A
    AIDS Behav; 2005 Mar; 9(1):27-39. PubMed ID: 15812611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study finds legalizing needles reduces HIV risk.
    AIDS Policy Law; 1995 Sep; 10(17):1, 11. PubMed ID: 11362806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of injection drug user (IDU) syringe sharing: the relationship between availability of syringes and risk network member characteristics in Winnipeg, Canada.
    Shaw SY; Shah L; Jolly AM; Wylie JL
    Addiction; 2007 Oct; 102(10):1626-35. PubMed ID: 17854339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study urges easing of syringe laws.
    AIDS Alert; 1996 Jul; 11(7):83. PubMed ID: 11363553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug problem in southeast and southwest Asia.
    Kulsudjarit K
    Ann N Y Acad Sci; 2004 Oct; 1025():446-57. PubMed ID: 15542748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Injection drug use in Rural Iran: integrating HIV prevention into iran's rural primary health care system.
    Mojtahedzadeh V; Razani N; Malekinejad M; Vazirian M; Shoaee S; Saberi Zafarghandi MB; Hernandez AL; Mandel JS
    AIDS Behav; 2008 Jul; 12(4 Suppl):S7-12. PubMed ID: 18521737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New York City injection drug users' memories of syringe-sharing patterns and changes during the peak of the HIV/AIDS epidemic.
    Rockwell R; Joseph H; Friedman SR
    AIDS Behav; 2006 Nov; 10(6):691-8. PubMed ID: 16708274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs.
    Ward J; Topp L; Iversen J; Wand H; Akre S; Kaldor J; Maher L
    Aust N Z J Public Health; 2011 Oct; 35(5):421-6. PubMed ID: 21973248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south-east Sydney.
    Bryant J; Topp L; Hopwood M; Iversen J; Treloar C; Maher L
    Drug Alcohol Rev; 2010 Jul; 29(4):364-70. PubMed ID: 20636651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of needle-exchange programs on the spread of HIV among injection drug users: a simulation study.
    Raboud JM; Boily MC; Rajeswaran J; O'Shaughnessy MV; Schechter MT
    J Urban Health; 2003 Jun; 80(2):302-20. PubMed ID: 12791806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is Vancouver Canada's supervised injection facility cost-saving?
    Pinkerton SD
    Addiction; 2010 Aug; 105(8):1429-36. PubMed ID: 20653622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pattern of injecting drug uses and HIV-1 infection: analysis from needle exchange program.
    Tellado I; Moran N; Vargas Vidot J; Yamamura Y
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1091-6. PubMed ID: 9449543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV infection among injecting drug users in Asia: an evolving public health crisis.
    Wodak A; Crofts N; Fisher R
    AIDS Care; 1993; 5(3):313-20. PubMed ID: 8218466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.